(Q45972761)

English

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Olga Yeshchina

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Gina M Badalato

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Matthew S Wosnitzer

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Gregory Hruby

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Arindam RoyChoudhury

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Mitchell C Benson

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Daniel P Petrylak

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

James M McKiernan

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

language of work or name

0 references

publication date

22 December 2011

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

79

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

384-390

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Current chemotherapeutic options for the treatment of advanced bladder cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.10.050

7 January 2021

Identifiers

10.1016/J.UROLOGY.2011.10.050

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22196406

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45972761&oldid=1584471655"